Inspiratory Flow Parameters With Placebo Easyhaler and Placebo HandiHaler
Status:
Completed
Trial end date:
2020-01-13
Target enrollment:
Participant gender:
Summary
The study will characterise inspiratory flow parameters across placebo dry powder inhaler
Easyhaler (2 inhaler versions) and placebo Spiriva inhalation powder capsule inhaled via
HandiHaler in patients with chronic obstructive pulmonary disease (COPD) and in healthy
volunteers.
Substudy: Easyhaler® and HandiHaler® Usability study in patients with COPD; to assess
patients acceptability, preference, correct use and ability to learn to use Easyhaler and
HandiHaler (with capsules) and to compare PIF rate via In-Check Dial meter with the PIF rate
via spirometer in the main study.